PURPOSE: To determine whether dynamic contrast material-enhanced magne
tic resonance (MR) imaging can help differentiate between malignant an
d benign mediastinal lymph nodes (MLNs) in bronchogenic carcinoma. MAT
ERIALS AND METHODS: Nine patients with biopsy-proved lung carcinoma un
derwent dynamic contrast-enhanced MR imaging before undergoing thoraci
c surgery. MR studies included spin-echo, electrocardiographically gat
ed axial and coronal sequences and transaxial gradient-echo breath-hol
d sequences, which were performed after administration of a bolus of g
adoterate meglumine. The enhancement curves were established on the ba
sis of mean signal intensities from regions of interest at the level o
f tumor and the enlarged MLN. MR images were compared with pathologic
specimens obtained at surgical resection. RESULTS: Metastatic MLNs exh
ibited their peak enhancement at 60-80 seconds, with a slow decrease u
ntil 6 minutes. Granulomatous and anthracotic lymph nodes displayed a
slight enhancement, with no peak within 6 minutes (P < .01). CONCLUSIO
N: Dynamic contrast-enhanced MR images may provide informative data ab
out the nature of enlarged MLNs in the preoperative assessment of lung
carcinoma. Further studies are needed to investigate its usefulness i
n clinical practice.